JPS63198995A - Production of l-threonine, collection of bacterium and cell of bacterium - Google Patents
Production of l-threonine, collection of bacterium and cell of bacteriumInfo
- Publication number
- JPS63198995A JPS63198995A JP2976987A JP2976987A JPS63198995A JP S63198995 A JPS63198995 A JP S63198995A JP 2976987 A JP2976987 A JP 2976987A JP 2976987 A JP2976987 A JP 2976987A JP S63198995 A JPS63198995 A JP S63198995A
- Authority
- JP
- Japan
- Prior art keywords
- threonine
- bacterium
- oxazolidine
- producing
- modn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 title claims abstract description 83
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 241000894006 Bacteria Species 0.000 title abstract description 13
- 239000004473 Threonine Substances 0.000 claims abstract description 49
- 229960002898 threonine Drugs 0.000 claims abstract description 49
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 241000588986 Alcaligenes Species 0.000 claims abstract description 9
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims abstract description 8
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 28
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 23
- 244000005700 microbiome Species 0.000 claims description 18
- 230000001580 bacterial effect Effects 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 3
- 239000003610 charcoal Substances 0.000 claims description 2
- 239000005973 Carvone Substances 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000000593 degrading effect Effects 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 abstract description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 6
- KYNKAUUXUQOZSQ-UHFFFAOYSA-N 5-methyl-2-oxo-1,3-oxazolidine-4-carboxylic acid Chemical compound CC1OC(=O)NC1C(O)=O KYNKAUUXUQOZSQ-UHFFFAOYSA-N 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 12
- 230000003287 optical effect Effects 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 235000013372 meat Nutrition 0.000 description 6
- 239000000284 extract Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000002306 biochemical method Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-STHAYSLISA-N D-threonine Chemical compound C[C@H](O)[C@@H](N)C(O)=O AYFVYJQAPQTCCC-STHAYSLISA-N 0.000 description 2
- 229930182822 D-threonine Natural products 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- AYFVYJQAPQTCCC-HRFVKAFMSA-N L-allothreonine Chemical compound C[C@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-HRFVKAFMSA-N 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920001397 Poly-beta-hydroxybutyrate Polymers 0.000 description 1
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- QLULGSLAHXLKSR-UHFFFAOYSA-N azane;phosphane Chemical compound N.P QLULGSLAHXLKSR-UHFFFAOYSA-N 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- -1 ethanol Chemical compound 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003588 threonines Chemical class 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は人の必須アミノ酸の1種であり、医薬品、食品
添加物等として有用なL−スレオニン(L−トレオニン
)の生化学的製造法、当該製造法に有効な微生物の取得
法、及び微生物菌体アルカリゲネス属YY−207株に
関する。Detailed Description of the Invention (Field of Industrial Application) The present invention is a biochemical method for producing L-threonine, which is one of the essential amino acids for humans and is useful as a pharmaceutical, food additive, etc. , a method for obtaining a microorganism effective for the production method, and a microorganism strain of the genus Alcaligenes YY-207.
(従来技術と問題点)
スレオニンは分子中に2原子の不斉炭素を有するため、
4種の光学異性体が存在するが、これら異性体の中で生
理的に活性な化合物、即ち、産業上有用な価値を有する
ものは現時点ではL−スレオニンに限られている。(Prior art and problems) Because threonine has two asymmetric carbon atoms in its molecule,
There are four types of optical isomers, but among these isomers, L-threonine is currently the only physiologically active compound, that is, one that has industrial value.
従来、L−スレオニンを製造するには蛋白質の加水分解
物から単離する方法と合成法が知られているが、L−ス
レオニンは他のアミノ酸と比べて蛋白質加水分解物から
単離するのが比較的困難であると言われている。一方、
合成法は有機化学的な方法と醗酵法、酵素法等の生化学
的な方法に大別され、前者の方法では通常DL−スレオ
ニン(スレオニンのラセミ体)が得られるため、L−ス
レオニンの製造には光学分割及びラセミ化の技術が不可
欠であり、更には、殆んどの場合DL−スレオニンの他
に生理的に不活性なアロスレオニン(DL一体)が一定
量副生ずることが避けられないため、それらとの分離、
精製の手間を含めて製造コストが嵩み、また、コストダ
ウンを図るにしても限度があるため経済的に問題が多い
。Traditionally, methods for producing L-threonine have been known, including isolation from protein hydrolysates and synthesis methods, but compared to other amino acids, it is easier to isolate L-threonine from protein hydrolysates. It is said to be relatively difficult. on the other hand,
Synthesis methods are roughly divided into organic chemical methods and biochemical methods such as fermentation methods and enzyme methods.The former method usually yields DL-threonine (racemic form of threonine), so it is difficult to produce L-threonine. Optical resolution and racemization techniques are indispensable for this, and in most cases, it is unavoidable that a certain amount of physiologically inactive allothreonine (DL itself) is produced as a by-product in addition to DL-threonine. , separation from them,
The production cost, including the labor involved in refining, is high, and even if efforts are made to reduce the cost, there are limits, resulting in many economic problems.
4種の光学異性体の中からL−スレオニンのみを選択的
に製造するため有効な方法として、生化学的な手段につ
いても従来より種々研究されており、古くは例えば、枯
草菌の変異株の培養液によるL−ホモ上11ンからの転
換が著名であり、他に各種微生物を用いた直接醗酵法や
前駆体醗酵法或いは合成化合物を酵素反応によりL−ス
レオニンに転換する方法が種々提案されているが、スレ
オニンの生合成系には所謂代謝制御があり、そのため直
接醗酵法に於いては通常の微生物ではスレオニンを一定
以上蓄積することは困難であり遺伝子の組替え等の手段
が不可欠である。また、前駆体を用いる方法では、前駆
体の取得自体に経済的な難点がある。一方、酵素反応に
よる方法・:しては2−オキサゾリジン誘導体を原料と
する方法(特開昭58−237130号)やスレオニン
異性体混合物の生化学的光学分割法等、が知られている
。しかし、合成化合物を用いる生化学的転換法と言えど
も実体は、単に加水分解や脱炭酸等の有機化学反応を酵
素反応に置き換えただけのものであり、従って原料とし
て使用する化合物には予めL−スレオニンに転換し得る
L一体を準備しなければならないものが多く、必ずしも
経済的に有利な方法とは言い難い、特に、スレオニンの
場合には前述の如く、隣接した2つの炭素原子が共に不
斉炭素であるため4種の異性体が存在し、しかも各異性
体をラセミ化した場合1例えば、D−スレオニンからは
通常L−アロスレオニンとの混合物が生じ、それを光学
分割してもL−スレオニンは得られない、異性体の光学
分割によりL−スレオニンを得るにはD−70スレオニ
ンをラセミ化し、それを分割することが必要である等他
の不斉炭素原子が1つしかないアミノ酸の光学分割と較
べ非常に面倒なことが多い。Various biochemical methods have been studied as an effective method for selectively producing only L-threonine from among the four optical isomers. Conversion from L-homogenine using a culture solution is well known, and various other methods have been proposed, including direct fermentation using various microorganisms, precursor fermentation, and methods for converting synthetic compounds to L-threonine through enzymatic reactions. However, the threonine biosynthesis system is subject to so-called metabolic control, and for this reason, it is difficult for normal microorganisms to accumulate threonine above a certain level in the direct fermentation method, and methods such as genetic recombination are indispensable. . Furthermore, in the method using a precursor, there are economical difficulties in obtaining the precursor itself. On the other hand, methods using an enzymatic reaction include a method using a 2-oxazolidine derivative as a raw material (JP-A-58-237130) and a biochemical optical resolution method of a mixture of threonine isomers. However, even though it is a biochemical conversion method using synthetic compounds, in reality it simply replaces organic chemical reactions such as hydrolysis and decarboxylation with enzymatic reactions, and therefore, the compounds used as raw materials are pre-prepared with L. - In many cases, it is necessary to prepare an L monolith that can be converted into threonine, and this method cannot necessarily be said to be economically advantageous. In particular, in the case of threonine, as mentioned above, two adjacent carbon atoms are both indispensable. Because it is a homogeneous carbon, four types of isomers exist, and when each isomer is racemized, 1 For example, D-threonine usually produces a mixture with L-allothreonine, and even if it is optically resolved, L - Threonine cannot be obtained; to obtain L-threonine by optical resolution of isomers, it is necessary to racemize D-70 threonine and resolve it, etc. Other asymmetric amino acids with only one carbon atom It is often very troublesome compared to optical separation.
(発明が解決しようとする課題)
そこで合成化合物を用いるL−スレオニンの生化学的製
造法に於いては、原料として出来るだけ安価な化合物を
用いること及びそれらの化合物からL−スレオニンのみ
を生成蓄積する、換言すれば、スレオ体−アロ体、L体
−D体を識別する能力を有する微生物(酵素系)を見い
出すことが肝要である。(Problem to be solved by the invention) Therefore, in the biochemical production method of L-threonine using synthetic compounds, it is necessary to use compounds as cheap as possible as raw materials and to generate and accumulate only L-threonine from these compounds. In other words, it is important to find microorganisms (enzyme systems) that have the ability to discriminate between threo-allo and L-d forms.
(課題の解決手段)
本発明は工業的に比較的安価に得られる5−メチル−2
−オキソ−オキサゾリジン−4−カルボン酸(以下MO
DNと略称する)を原料とし、これを生化学的な手段に
よりL−スレオニンに選択的に転換する方法及びこの方
法に効果的な微生物の取得法並びに新規な微生物を提供
せんとするものである。(Means for solving the problem) The present invention provides 5-methyl-2 which can be obtained industrially at relatively low cost.
-oxo-oxazolidine-4-carboxylic acid (hereinafter MO
The present invention aims to provide a method for selectively converting L-threonine into L-threonine by biochemical means, a method for obtaining microorganisms effective for this method, and a novel microorganism. .
即ち、本発明は5−メチル−2−オキソ−オキサゾリジ
ン−4−カルボン酸をL−スレオニン生産能を有する微
生物、培養液または菌体処理物に作用させることを特徴
とするL−スレオニンの製造法及び5−メチル−2−オ
キソ−オキサゾリジン−4−カルボン酸の分解能を有す
る微生物を5−オキソプロリンを唯一の炭、窒素源とす
る培地で培養し、生育した菌株を採取することを特徴と
する5−メチル−2−オキソ−オキサゾリジン−4−カ
ルボン酸よりのL−スレオニン生産性微生物の取得方法
に関する。また、この方法によって土壌より分離された
代表的な微生物としてアルカリゲネス属に属する新規な
バクテリア、アルカリゲネスYY−207株(昭和62
年2月θ日付で工業技術院微生物工業技術研究所に微工
研菌寄第8180号として寄託されている。)が提供さ
れる。That is, the present invention provides a method for producing L-threonine, which is characterized by allowing 5-methyl-2-oxo-oxazolidine-4-carboxylic acid to act on a microorganism capable of producing L-threonine, a culture solution, or a treated bacterial cell product. and 5-methyl-2-oxo-oxazolidine-4-carboxylic acid is cultured in a medium containing 5-oxoproline as the sole charcoal and nitrogen source, and the grown strain is collected. The present invention relates to a method for obtaining L-threonine-producing microorganisms from 5-methyl-2-oxo-oxazolidine-4-carboxylic acid. In addition, as a representative microorganism isolated from soil by this method, a new bacterium belonging to the genus Alcaligenes, Alcaligenes YY-207 strain (1982
It has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology as February θ, 2013, as Microtechnology Research Institute No. 8180. ) is provided.
以下本発明の方法について更に詳しく説明する。The method of the present invention will be explained in more detail below.
化学的にMODNをスレオニンに転換する場合、L−)
ランスMODNからはL−スレオニンが得られるが、D
−)ランスMODNからはD−スレオニン、L−シスM
ODNからはL−70スレオニン、D−シスMODNか
らはD−70スレオニンが得られる0本発明者らは本発
明についての研究当初、MODNの各異性体の中からL
−トランスMODNのみを選択的に分解する能力を有す
る微生物を採取するため、土壌中より分離した微生物を
L−トランスMODNを含む合成培地にて培養し、L−
スレオニンの生成蓄積の有無を調べてみた処、MODN
の分解能を有する微生物はいくつか見つかったが、いず
れもL−スレオニンの蓄積は少なく、従って実用に供す
るには程遠いものであった。When chemically converting MODN to threonine, L-)
L-threonine is obtained from lance MODN, but D
-) D-threonine, L-cis M from Lance MODN
L-70 threonine is obtained from ODN, and D-70 threonine is obtained from D-cis MODN. At the beginning of the research on the present invention, the present inventors obtained L-70 threonine from each isomer of MODN.
- In order to collect microorganisms that have the ability to selectively decompose only trans-MODN, microorganisms isolated from soil are cultured in a synthetic medium containing L-trans-MODN.
I investigated the presence or absence of threonine production and accumulation, MODN
Although several microorganisms having the ability to decompose L-threonine have been found, they all accumulate a small amount of L-threonine, and are therefore far from being of practical use.
そこで更に当該微生物を5−オキソプロリンを含む培地
で培養し、この5−オキソプロリンのみを炭素及び窒素
源とする培地で生育する菌株を採取して、これを生理的
食塩水に懸濁しMODNと反応させた処し−スレオニン
が高収率で生成することを見出した。Therefore, the microorganism was further cultured in a medium containing 5-oxoproline, and a strain that grew in a medium containing only 5-oxoproline as a carbon and nitrogen source was collected, and this was suspended in physiological saline and combined with MODN. It has been found that the reacted product produces threonine in high yield.
このようにして得られた菌株の代表的なものとして前記
アルカリゲネス属YY−207株が挙げられるが、その
取得方法及び菌学的性質を以下に示す。A typical strain thus obtained is the Alcaligenes strain YY-207, and its acquisition method and mycological properties are shown below.
土壌懸濁液を別表1に示すMODNを含む液体培地に接
種し、30℃で数日間培養した。さらにこの培養液1滴
を同液体培地に移し、30℃で数日間培養した。この操
作を数回くりかえしたのち、その培養液を同じ寒天培地
にまいて培養し、生育の認められたコロニーを分離した
。The soil suspension was inoculated into a liquid medium containing MODN shown in Attached Table 1, and cultured at 30°C for several days. Furthermore, one drop of this culture solution was transferred to the same liquid medium and cultured at 30°C for several days. After repeating this operation several times, the culture solution was spread on the same agar medium and cultured, and colonies that were observed to grow were isolated.
この分離菌のそれぞれについて、別ifに示す培地5膳
立に接種し、28℃で48時間振とぅ培養ののち、除菌
し上清のMODNを定量しMODN分解能をもつもの1
0株が分離できた。Each of these isolated bacteria was inoculated into 5 sets of media shown in separate if, and after shaking culture at 28°C for 48 hours, bacteria were removed and MODN in the supernatant was quantified.
0 strains were isolated.
次に別表2に示す5−オキツブロリンを唯一の炭素源と
する培地で生育する菌体を探したところ、2株が得られ
た。これを集菌して、それぞれ70ミリモル リンSa
衝液(pH7)に懸濁して、MODNと反応させたとこ
ろ、MODNを分解しなおかつスレオニンを蓄積する菌
株YY−207株が見い出された。Next, we searched for bacterial cells that can grow in a medium containing 5-ocitubroline as the sole carbon source shown in Attached Table 2, and found two strains. Collect these bacteria and add 70 mmol of phosphorus Sa to each
When suspended in a buffer solution (pH 7) and reacted with MODN, strain YY-207 was found to decompose MODN and accumulate threonine.
表 1
L −) 5 ンスーMODN 0.5%
KH2P0. 0.0
5に2HP0. 0.
05Mg504−7H200,05
(pH7)
表 2
5−オキソプロリン 0.5%KH2P
O40,05
に2HPO40,05
Mg5O4−71(200,05
(pH7)
〔菌学的性質〕
(A)形態
(1)栄養細胞の大きさ:
0.8〜0.7 X 1.4〜1.5 μ膳(2
)細胞の多形性:
なし
く3)ダラム染色性:
陰性
(4) !f!動性:
有
(5)鞭毛:
周鞭毛
(6)胞子:
形成しない
(B)培養所見
(1)ペプトン培地
pH: 9.4〜3.2生育する。特にp)+ 7.
2〜4.3で生育良好
生育温度:
上限40℃で生育するが、42℃では生育しない。Table 1 L-) 5 MODN 0.5%
KH2P0. 0.0
5 to 2HP0. 0.
05Mg504-7H200,05 (pH7) Table 2 5-oxoproline 0.5%KH2P
O40,05 to 2HPO40,05 Mg5O4-71 (200,05 (pH 7) [Bacteriological properties] (A) Morphology (1) Size of vegetative cells: 0.8-0.7 X 1.4-1. 5μzen (2
) Cell pleomorphism: None 3) Durham staining: Negative (4)! f! Mobility: Yes (5) Flagella: Perifelgate (6) Spores: Not formed (B) Culture findings (1) Peptone medium pH: 9.4-3.2 Growth. Especially p)+7.
Growth is good at temperatures between 2 and 4.3 Growth temperature: Grows at an upper limit of 40°C, but does not grow at 42°C.
(2)他の培j1!I:
肉エキス・寒天斜面培地
生育良好、拡布状、薄黄白色光沢
肉エキス・寒天平板培地
径2〜3膳■48時間1円形隆起状、全縁薄黄白色光沢
肉エキス・液体培地
生育良好、混濁、沈澱有、菌膜状
肉汁ゼラチン穿刺培養
糸状、液化せず
リドマスミルク
アルカリ性
(3)酸素に対する態度
好気的
(C)生理学的性質
(1)硝酸塩の還元 +(2)VPテ
スト −(3)インドールの生成
−(0デンプンの加水分解 士
(5)クエン酸の利用 +(6)色素の
生成 −(7)ウレアーゼ
・ −(8)オキシダーゼ +
(9)カタラーゼ +(10)O−
Fテスト Oxd、±(11)脱窒反応
+(12) MRテスト
−(13)硫化水素の生成
+(10無機窒素源の利用 +(15)糖
類からの酸及びガスの生成
糖 酸生成 ガス発生
L−アラビノース ± −D−キシロース
士 −〇−グルコース ±
−D−マンノース ± −D−フ
ラクトース 士 −
D−ガラクトース ± −麦芽糖
士 −
ショ糖 士 −
乳糖 −−
トレハロース ± −D−ソルビット
± −D−マンニット ±
−イノジット − −グリ
セリン ± −
デンプン ± −(1B)その他
の作用
ゼラチン及びカゼインを加水分解しない。(2) Other cultivation j1! I: Meat extract, good growth on agar slanted medium, spreading shape, light yellowish-white glossy meat extract, agar plate medium diameter 2 to 3 servings ■ 48 hours 1 circular ridge shape, pale yellowish-white glossy meat extract on all edges, good growth on liquid medium , turbidity, precipitate, fungal membrane Meat juice Gelatin puncture culture Filamentous, not liquefied Lidomus milk alkaline (3) Attitude towards oxygen Aerobic (C) Physiological properties (1) Nitrate reduction + (2) VP test - (3) Generation of indole
- (0) Hydrolysis of starch (5) Utilization of citric acid + (6) Production of pigment - (7) Urease
・-(8) Oxidase +
(9) Catalase + (10) O-
F test Oxd, ± (11) denitrification reaction
+(12) MR test
-(13) Generation of hydrogen sulfide
+ (10 Utilization of inorganic nitrogen sources + (15) Production of acid and gas from sugars Sugar Acid production Gas production L-arabinose ± -D-xylose -〇-glucose ±
-D-mannose ± -D-fructose -D-galactose ± -maltose
- sucrose - lactose - trehalose ± -D-sorbitol ± -D-mannitol ±
- Inozite - - Glycerin ± - Starch ± - (1B) Other effects Does not hydrolyze gelatin and casein.
ポリ−β−ヒドロキシブチレート存在する。Poly-β-hydroxybutyrate is present.
前記したアルカリゲネスYY−207菌等のMODNよ
りL−スレオニン生産能を有する微生物の培養について
は特に制限はないが、一般に炭素源、窒素源、無機塩等
を含む合成または天然培地にて5−オキツブロリンを0
.1〜2賛t%、好ましくは0.5〜1 wt%程度添
加して好気的に培養される。炭素源としてはブドウ糖、
精密、デン粉糖化液、セルロース分解物などの糖類、酢
酸などの有機酸、エタノールなどのアルコール等菌が資
化し得るものであれば特に制限はなく、また、窒素源と
してはアンモニア、硫安、塩安、硝安、燐安などのアン
モニウム塩や尿素、硝酸塩等が適宜用いられる。無機塩
としては燐酸、カリウム、マグネシウム、鉄、マンガン
等の塩類例えば、燐酸アンモニウム、燐酸カリ、硫酸カ
リ、苛性カリ、硫酸マグネシウム、硫酸第一鉄、硫酸マ
ンガン等の通常の工業用薬品で良く、他に微量元素とし
てカルシウム、ナトリウム、亜鉛、硼素、銅、コバルト
、モリブデン等の塩類を加えても良い、また微量有機栄
養素としてビタミン、アミノ酸等は菌の生育上は特別に
必要とするものではないが、これらを添加したり、コー
ンスチープリカー、肉エキス、酵母エキス、ペプトン、
等の有機物を加えても良い。There are no particular restrictions on the cultivation of microorganisms capable of producing L-threonine from MODN, such as the above-mentioned Alcaligenes YY-207 bacteria, but 5-oxtubebroline is generally cultured in a synthetic or natural medium containing a carbon source, nitrogen source, inorganic salts, etc. 0
.. About 1 to 2 t%, preferably about 0.5 to 1 wt%, is added and cultured aerobically. Glucose as a carbon source,
There is no particular restriction as long as it can be assimilated by bacteria, such as sugars such as sugars, starch saccharified liquid, and cellulose decomposition products, organic acids such as acetic acid, alcohols such as ethanol, etc. Nitrogen sources include ammonia, ammonium sulfate, and salts. Ammonium salts such as ammonium ammonium, ammonium nitrate, ammonium phosphorus, urea, nitrates, etc. are used as appropriate. Examples of inorganic salts include salts such as phosphoric acid, potassium, magnesium, iron, and manganese; for example, common industrial chemicals such as ammonium phosphate, potassium phosphate, potassium sulfate, caustic potassium, magnesium sulfate, ferrous sulfate, and manganese sulfate; and others. Salts such as calcium, sodium, zinc, boron, copper, cobalt, and molybdenum may be added as trace elements, and vitamins and amino acids as trace organic nutrients are not particularly required for the growth of bacteria. , these can be added, corn steep liquor, meat extract, yeast extract, peptone,
You may also add organic substances such as
培養は振とう培養1通気撹拌培養等の好気的条件下で行
なうが、培養温度は25〜45℃、p)Iは5.0〜9
.0、好ましくは8〜8の範囲が至適である。Culture is carried out under aerobic conditions such as shaking culture 1 aeration stirring culture, culture temperature is 25-45°C, p)I is 5.0-9
.. 0, preferably in the range of 8 to 8.
本発明の方法によるL−スレオニンの製造の態様につい
ては特に制限はないが、通常は培養液より分離した菌体
を生理食塩水に懸濁した液にMODNを添加して反応さ
せる。しかし、場合によっては菌体培養液をそのまま用
いても或いは菌体処理物を用いても良い。Although there are no particular limitations on the manner in which L-threonine is produced by the method of the present invention, MODN is usually added to a solution in which bacterial cells isolated from a culture solution are suspended in physiological saline and reacted. However, depending on the case, the bacterial cell culture solution may be used as it is, or a bacterial cell-treated product may be used.
反応条件についても特別な制限はないが、一般に以下の
条件で反応させることが適当である。Although there are no particular restrictions on the reaction conditions, it is generally appropriate to carry out the reaction under the following conditions.
反応温度:20〜35℃、好ましくは25〜30℃、p
H: s−o〜9.0.好ましくは8.0〜8.0、
菌体濃度:20〜200層g/■文、MODN:菌体濃
度に比例するが通常50〜500■mol / fL、
反応時間:10〜24時間、好ましくは15〜20時間
。Reaction temperature: 20-35°C, preferably 25-30°C, p
H: so~9.0. Preferably 8.0 to 8.0,
Bacterial cell concentration: 20 to 200 layers g/ml, MODN: Proportional to bacterial cell concentration, but usually 50 to 500 mol/fL,
Reaction time: 10-24 hours, preferably 15-20 hours.
反応液からのL−スレオニンの分離、回収及び分析は公
知の方法を用いることが出来る。Known methods can be used for separation, recovery, and analysis of L-threonine from the reaction solution.
例えば、反応液から遠心分離等で菌体を除去したのち、
常法に従って、カチオン交換樹脂と7ニオン交換樹脂で
、吸・親処理して精製し濃縮して、必要とあらば等電点
晶析を行って単離することが出来る。For example, after removing bacterial cells from the reaction solution by centrifugation,
According to a conventional method, it can be purified and concentrated by adsorption/philic treatment using a cation exchange resin and a 7-ion exchange resin, and if necessary, it can be isolated by performing isoelectric focusing crystallization.
L−スレオニンの同定は、アミノ酸分析計。L-threonine was identified using an amino acid analyzer.
IRスペクトル、マススペクトル、核磁気共鳴スペクト
ルにより行うことが出来る。This can be performed using IR spectrum, mass spectrum, or nuclear magnetic resonance spectrum.
L−スレオニンの光学純度は旋光度針を用いて測定する
が、市販の光学分割カラムクロマトグラフィーを用いる
ことにより、更に精度良く分析出来る。The optical purity of L-threonine is measured using an optical rotation needle, but it can be analyzed with higher accuracy by using commercially available optical resolution column chromatography.
実施例1
表aで示した栄養培地を用いて、YY−207株を24
時間30℃で培養した。遠心分離した菌体な160履g
/膳見の割合でリン酸緩衝液に懸濁させ、DL−トラン
ス・MODNIOGミリモル濃度で仕込み30℃で18
時間反応した。Example 1 Using the nutrient medium shown in Table a, 24 strains of YY-207 were grown.
The cells were cultured at 30°C for an hour. 160g of centrifuged bacterial cells
DL-trans/MODNIOG was suspended in a phosphate buffer at a ratio of
Time reacted.
液組成を高速液体クロマトグラフィーで分析したところ
未反応のDL−)ランス−MODNと、スレオニン25
ミリモルが検出され、光学分割カラムクロマトグラフィ
ーより、純粋なL−スレオニンであることが確かめられ
た。菌体分離ののち、カチオン交換樹脂に通し、吸着分
をアンモニア水にて溶出し、さらにアニオン交換樹脂で
処理し、水溶液を数十倍に濃縮することにより、白色結
晶が得られた。Analysis of the liquid composition by high performance liquid chromatography revealed that unreacted DL-)lance-MODN and threonine 25
Millimoles were detected, and it was confirmed by optical resolution column chromatography that it was pure L-threonine. After bacterial cell separation, it was passed through a cation exchange resin, the adsorbed content was eluted with aqueous ammonia, and further treated with an anion exchange resin, and the aqueous solution was concentrated several tens of times to obtain white crystals.
この白色結晶の元素分析値、IRスペクトル、マススペ
クトル、各磁気共鳴スペクトル(D20溶媒)はL−ス
レオニン標準値とよく一致した。The elemental analysis values, IR spectrum, mass spectrum, and magnetic resonance spectra (D20 solvent) of this white crystal were in good agreement with the L-threonine standard value.
また比旋光度は〔α) =−33,5° (C=1H
2O)であった。Also, the specific optical rotation is [α) = -33,5° (C = 1H
2O).
実施例2
実施例1と同様、但し基質にシス体とトランス体が2ニ
アの割合で混合したMODNを用いて反応させたところ
、18時間反応後の液中に未反応のMODNとL−スレ
オニン23ミリモル濃度が検出され、光学分割カラムク
ロマトグラフィー(キラルパックWH型)より純粋なL
−スレオニンであることかたしかめられ、アロ体の生成
は認められなかった。Example 2 The reaction was carried out in the same manner as in Example 1, except that MODN in which the cis and trans forms were mixed at a ratio of 2 was used as the substrate. A concentration of 23 mmol was detected, and pure L was determined by optical resolution column chromatography (Chiral Pack WH type).
- It was confirmed that it was threonine, and no alloform was observed.
比較例(培養条件の検討)
栄養培地(表a)MODN培地(表b)5−オキソプロ
リン培地(表C)で培養した菌体を用いてそれぞれリン
酸緩衝液1 11JI中に(p)I?)MODNIOミ
リモルを入れ30℃で反応させた。Comparative Example (Study of Culture Conditions) Using bacterial cells cultured in nutrient medium (Table a), MODN medium (Table b), and 5-oxoproline medium (Table C), (p)I was added in 1 to 11 JI of phosphate buffer, respectively. ? ) Millimoles of MODNIO were added and reacted at 30°C.
反応終了後、2分間煮沸して除菌ののち、上積を分析し
たところ、24時間のちでも前2者由来の反応液にスレ
オニンの蓄積は認めらつれず、5−オキツブロリン培地
由来のもののみに4ミリモルのスレオニンの存在が認め
られた。After the completion of the reaction, after sterilization by boiling for 2 minutes, the supernatant was analyzed. Even after 24 hours, no accumulation of threonine was observed in the reaction solutions derived from the first two, only those derived from the 5-oxytubroline medium. The presence of 4 mmol of threonine was observed.
表 a
ペプトン 1.0%肉エキス
1.0
Mail 0.5表 b
L−)ランスMODN 0.25%KH2PO
40,l
MgSO4・7H200,05
FeSOa ’ 7H200,001
MnSO4・7H200,000?
(pH7)
表 C
5−オキソプロリン 0.25%KH2PO4
0,l
MgSO4・71(200,05
FeSOa ・?H200,001
Mn504 ” 7H200,000?(pH7)Table a Peptone 1.0% meat extract
1.0 Mail 0.5 Table b L-) Lance MODN 0.25%KH2PO
40,l MgSO4・7H200,05 FeSOa ' 7H200,001 MnSO4・7H200,000? (pH 7) Table C 5-oxoproline 0.25%KH2PO4
0,l MgSO4・71(200,05 FeSOa・?H200,001 Mn504” 7H200,000?(pH7)
Claims (3)
カルボン酸をLスレオニン生産能を有する微生物、培養
液または菌体処理物に作用させることを特徴とするL−
スレオニンの製造法。(1) 5-methyl-2-oxo-oxazolidine-4-
L-, which is characterized in that a carboxylic acid is applied to a microorganism capable of producing L-threonine, a culture solution, or a processed product of bacterial cells.
Method for producing threonine.
カルボン酸の分解能を有する微生物を5−オキソプロリ
ンを唯一の炭、窒素源とする培地で培養し、生育した菌
株を採取することを特徴とする5−メチル−2−オキソ
−オキサゾリジン−4−カルボン酸よりのL−スレオニ
ン生産性微生物の取得方法。(2) 5-methyl-2-oxo-oxazolidine-4-
5-Methyl-2-oxo-oxazolidine-4-carvone, which is characterized by culturing microorganisms capable of degrading carboxylic acids in a medium containing 5-oxoproline as the sole charcoal and nitrogen source, and collecting the grown strains. Method for obtaining L-threonine-producing microorganisms from acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2976987A JPS63198995A (en) | 1987-02-13 | 1987-02-13 | Production of l-threonine, collection of bacterium and cell of bacterium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2976987A JPS63198995A (en) | 1987-02-13 | 1987-02-13 | Production of l-threonine, collection of bacterium and cell of bacterium |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63198995A true JPS63198995A (en) | 1988-08-17 |
Family
ID=12285246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2976987A Pending JPS63198995A (en) | 1987-02-13 | 1987-02-13 | Production of l-threonine, collection of bacterium and cell of bacterium |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63198995A (en) |
-
1987
- 1987-02-13 JP JP2976987A patent/JPS63198995A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4492757A (en) | Process for preparing L-threonine | |
EP0434393B1 (en) | Process for preparation of R-(-)-3-halogeno-1,2-propanediol by treatment with microorganism | |
US5212089A (en) | Process for prepartion of s-(+)-3-halogeno-1,2-propanediol by treatment with alcaligenes | |
JPS63198995A (en) | Production of l-threonine, collection of bacterium and cell of bacterium | |
JP3116102B2 (en) | Method for producing L-3,4-dihydroxyphenylalanine | |
JP3006907B2 (en) | Method for producing L-alanine by fermentation method | |
US5246843A (en) | Process for preparation of R-(-)-3-halogeno-1,2,-propanediol by treatment with microorganism | |
EP0205303B1 (en) | Microbiological method of producing ethylene | |
EP0187525B1 (en) | Process for producing l-serine | |
EP0310949B1 (en) | Process for producing d-alanine | |
JPS58201992A (en) | Preparation of beta-substituted propionic acid or amide thereof by microorganism | |
JPS63198994A (en) | Production of l-serine | |
CN100396782C (en) | Preparation method of stable isotop labelled 15N-L-asparagic acid | |
JP4306453B2 (en) | Production of S-form 1,2-propanediol by using microorganisms | |
JPH0151999B2 (en) | ||
CN117866777A (en) | Fusarium graminearum for producing xylose, and culture method and application thereof | |
JPS6342692A (en) | Production of l-isoleucine | |
JPH03180196A (en) | Production of optically active epichlorohydrin | |
JPS63126495A (en) | Novel antibiotic substance 6257 and production thereof | |
JPH06181787A (en) | Production of l-alpha-aminoadipic acid | |
JPS6112677B2 (en) | ||
JPH06245782A (en) | Production of trans-4-hydroxy-l-proline | |
JPH02257874A (en) | Bacterial strain of genus rhodococcus and production of 2-hydroxybutyric acid using the same | |
JPH0539B2 (en) | ||
JPS61152292A (en) | Production of l-serine |